Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Nivolumab
Ipilimumab
Locations
1
Germany
Universitätsmedizin Mannheim, Heidelberg University, II. Medizinische Klinik
Mannheim, Germany
Start Date
February 21, 2018
Primary Completion Date
November 19, 2021
Completion Date
November 19, 2021
Last Updated
September 29, 2022
NCT06713993
NCT06257264
NCT00242723
NCT05005403
NCT06253871
NCT04674267
Lead Sponsor
AIO-Studien-gGmbH
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions